JBS N.V. reported record net sales of $22.6 billion for Q3 2025, driven by growth across all business units, notably in its Seara and Pilgrim’s Pride segments. The company achieved an adjusted EBITDA of $1.8 billion, reflecting an 8.1% margin, despite facing challenges from a tightening U.S. beef cycle and higher livestock costs. Free cash flow declined significantly to $383 million, primarily due to increased capital expenditures and working capital needs.
This performance highlights JBS’s resilience in a challenging market, with the company maintaining a leverage ratio of 2.39x and completing a $600 million share buyback program. The lifting of export bans to Europe and China for Seara is expected to enhance margins further, while ongoing investments in U.S. pork capacity are projected to add $500 million to $750 million in revenue by 2027.
For market professionals, JBS’s ability to navigate supply constraints while expanding its operational capacity suggests a strategic focus on long-term growth, making it a company to watch as global protein demand continues to rise.
Source: fool.com